Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
immuno-oncology
Biotech
Genentech to close cancer immunology research department
Star cell biologist Ira Mellman, who has been with Genentech for 17 years and is credited for the introduction of Tecentriq, will leave the company.
Angus Liu
Aug 16, 2024 11:08am
ALX's fizzling CD47 response rate sends stock spiraling down
Aug 1, 2024 5:34am
BioNTech, Regeneron rack up response rate win for cancer vaccine
Jul 30, 2024 6:45am
Immutep regains pep as cancer subgroup data show path forward
Jul 12, 2024 9:35am
Innovent links IL-2 fusion protein to responses in small study
Jun 14, 2024 10:00am
Ipsen, Marengo ink $1.2B biobuck deal to treat cold tumors
Jun 7, 2024 9:15am
